Information Provided By:
Fly News Breaks for August 14, 2018
HCA
Aug 14, 2018 | 06:35 EDT
Barclays analyst Steven Valiquette started HCA Healthcare with an Overweight rating and $150 price target.
News For HCA From the Last 2 Days
HCA
HCA
HCA
Apr 29, 2024 | 07:41 EDT
Oppenheimer analyst Michael Wiederhorn raised the firm's price target on HCA Healthcare to $345 from $330 and keeps an Outperform rating on the shares. HCA produced strong Q1 2024 results, driven by continued traction with cost management efforts and robust top-line trends, the firm says. Underlying these results, management noted that Medicaid was weaker, while commercial was stronger due to Medicaid redeterminations. Despite the beat, HCA maintained FY2024 guidance, Oppenheimer adds.
HCA
I agree to the thefly.com's disclaimer & terms of use
About Privacy Terms of Use

© 1996-2018 TheStreet, Inc., 14 Wall Street, 15th Fl, NY, NY 10005

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.